CWS
EBS icon

Confluence Wealth Services’s Emergent Biosolutions EBS Stock Holding History

Confluence Wealth Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-253
Closed -$10K – 469
2021
Q4 		$10K Buy
+253
New +$11.4K ﹤0.01% 912

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Confluence Wealth Services's EBS Position: Q1 2022 in Review

Confluence Wealth Services sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 253 shares — an estimated $10K sold.

Confluence Wealth Services first reported a position in EBS in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

  • Confluence Wealth Services reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
  • Confluence Wealth Services sold 253 Emergent Biosolutions shares in Q1 2022, an estimated $10K.
  • Confluence Wealth Services first reported a position in Emergent Biosolutions in Q4 2021 and held it in 1 quarter.
  • Confluence Wealth Services's Emergent Biosolutions position peaked at $10K in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Confluence Wealth Services's 13F filing for Q1 2022, filed 26 Apr 2022.